Early growth response 2 as a target of IL-13/STAT6 signaling induces the goblet cell metaplasia of allergic airway epithelia
Allergology International · 2026-04 · 75 (2) · 327-337
DOI: 10.1016/j.alit.2026.01.002 ↗Kurz gefasst
Fachartikel in der Zeitschrift Allergology International, 2026-04. Verfasst von Chengyun Xu und 11 weiteren Autor:innen. Beteiligte Einrichtung: People's Hospital of Anji, Affiliated Anji Hospital, School of Medicine, Hangzhou City University, Hangzhou, China; Key Laboratory of Quantum Materia…. Hauptthemen laut MEDLINE: Signal Transduction, Early Growth Response Protein 2, Goblet Cells, Asthma. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Zhejiang Province.
Abstract (Originalsprache)
BACKGROUND: Airway epithelial goblet cell metaplasia is a cardinal feature of allergic asthma and is associated with the morbidity and mortality of this disease, While IL-13/STAT6 signaling is known to drive mucus metaplasia. Early growth response 2 (EGR2), an IL-4/STAT6-responsive transcription factor, is implicated in epithelial remodeling but its specific role in asthmatic goblet cell metaplasia has not been mechanistically established. METHODS: Human asthmatic airway biopsies and murine allergic inflammation models (OVA/challenge) were used to detect the expression of EGR2. Pharmacological STAT6 inhibition (AS1517499), adenoviral EGR2 knockdown, and adeno-associated-viral EGR2 overexpression were employed to dissect hierarchical regulation. Mucin dynamics were quantified via periodic acid-Schiff staining and MUC5AC immunofluorescence staining. Airway hyperresponsiveness (AHR) was assessed by RC system. Chromatin immunoprecipitation (ChIP) and luciferase reporter assays identified direct transcriptional targets. RESULTS: It was found that expression of EGR2 but not EGR1 and EGR3 was significantly upregulated in airway epithelia of mouse model with allergic airway inflammation or of children with allergic asthma. Whereas inhibition of STAT6 by its specific inhibitor, AS1517499, robustly attenuated not only the EGR2 expression but also the goblet cell metaplasia and mucous hypersecretion in response to IL-13 or allergen. Moreover, adenoviral knockdown of EGR2 expression in airway epithelia significantly attenuated the goblet cell metaplasia and mucous hypersecretion in response to IL-13 or allergen, and consistently attenuated the airway hyperresponsiveness in response to allergen. Whereas adeno-associated-viral overexpression of EGR2 in airway epithelia significantly enhanced the basal as well as allergen-induced goblet cell metaplasia and mucous hypersecretion. Finally, we identify that Muc5ac gene encoding MUC5AC mucin serves as a direct target of EGR2 in response to IL-13. CONCLUSIONS: Together, upregulation of EGR2 expression in allergic airway epithelia contributes to the goblet cell metaplasia and mucous hypersecretion, and intervention of EGR2 is thus a promising approach in the therapy of the cardinal feature of asthma.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- People's Hospital of Anji, Affiliated Anji Hospital, School of Medicine, Hangzhou City University, Hangzhou, China; Key Laboratory of Quantum Materials Control of Zhejiang Province, School of Information and Electrical…
- Department of Respirology, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China; National Clinical Research Center for Child Health, The Children's Hospital of Zhejiang University School of…
- Key Laboratory of Quantum Materials Control of Zhejiang Province, School of Information and Electrical Engineering, Hangzhou City University, Hangzhou, China.
- Department of Pharmacology, School of Medicine, Zhejiang University, Hangzhou, China.
- Department of Clinical Pharmacology, The Affiliated Women Hospital, Zhejiang University School of Medicine, Hangzhou, China.
- People's Hospital of Anji, Affiliated Anji Hospital, School of Medicine, Hangzhou City University, Hangzhou, China.
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Zhejiang Province
Zitieren
APA
Xu, C., Cai, Y., Chen, Q., He, Y., Yang, Y., Tan, D., Zhu, L., Wang, X., Tang, L., Wu, X., Zhou, M., & Lu, M. (2026). Early growth response 2 as a target of IL-13/STAT6 signaling induces the goblet cell metaplasia of allergic airway epithelia. Allergology International, 75(2), 327-337. https://doi.org/10.1016/j.alit.2026.01.002
Vancouver
Xu C, Cai Y, Chen Q, He Y, Yang Y, Tan D, et al. Early growth response 2 as a target of IL-13/STAT6 signaling induces the goblet cell metaplasia of allergic airway epithelia. Allergology International. 2026;75(2):327-337. doi:10.1016/j.alit.2026.01.002
BibTeX
@article{Xu2026,
author = {Xu, Chengyun and Cai, Yuqing and Chen, Qihang and He, Yangyun and Yang, Yuanyuan and Tan, Dan and Zhu, Liyin and Wang, Xiangzhi and Tang, Lanfang and Wu, Ximei and Zhou, Min and Lu, Meiping},
title = {Early growth response 2 as a target of IL-13/STAT6 signaling induces the goblet cell metaplasia of allergic airway epithelia},
journal = {Allergology International},
year = {2026},
volume = {75},
number = {2},
pages = {327--337},
doi = {10.1016/j.alit.2026.01.002}
}
EUVIMED